Israel headquartered Healthy.io, the category creator of smartphone urinalysis and the global leader in turning sma...
BioMed X on 13 Jan 2020 announced the start of a new joint research group in collaboration with Boehringer Ingelhei...
Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for the number of studies...
US based WuXi Advanced Therapies (AT), a leading global Contract Development and Manufacturing Organization (CDMO) offer...
Eli Lilly and Company and Dermira, Inc. have announced a definitive agreement for Lilly to acquire Dermira&nbs...
Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA)...
SOTIO, a biotechnology company owned by the PPF Group, on 8 Jan 2020 announced the opening of offices of SOTIO Biotech A...
When launched, Ingelvac CircoFLEX® was the first PCV2 vaccine that could be freshly mixed with an M hyo vaccine...
France headquartered genOway, a public company and leader in developing genetically modified research models, has announ...
Colgate has introduced a first-of-its-kind smart toothbrush with new optic sensor technology that detects biofilm buildu...
US based Pulmatrix, Inc., a clinical stage biopharmaceutical company developing innovative inhaled therapies to address ...
GlaxoSmithKline has announced the completion of the divestment of travel vaccines Rabipur (tradename Rabavert in the US)...
US based Purdue University drug discovery researchers have created a new framework for mining data for training mac...
The spinal muscular atrophy (SMA) market across the five growth markets ((5GM) Australia, China, India, Japan and South ...
Asia has driven a boom in recent years in terms of R&D spending, venture capital funding, academic publications, and...
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, today announced ...
The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of m...
Swedish company BioInvent International AB has announced that Pfizer Inc. has selected the second target under the compa...
